LRRK2 and Parkinson disease: Gly2019Ser is the most common LRRK2 mutation, and is present at high frequencies mainly in amongst North African and Arabs idiopathic and hereditary PD patients at 39% and 36% correspondingly, as well as in Caucasian PD patients,33 but Gly2019Ser is a rare mutation in Asian populations.11